Submissions from 2023
Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010-2019 Retrospective Cohort Study, Shreya Saxena, Atulya Khosla, Ahmad Ozair, Rupesh Kotecha, and Manmeet Ahluwalia
Disruption of National Cancer Database Data Models in the First Year of the COVID-19 Pandemic, Vicki Hawhee
Feasibility study of utilizing Sphinx for quality assurance in uniform scanning proton therapy, Suresh Rana
Hospital outcomes of patients receiving catheter ablation of atrial fibrillation, left atrial appendage closure, or both, Muni Rubens, Anshul Saxena, Venkataraghavan Ramamoorthy, and Emir Veledar
Temporally modulated pulsed proton re-irradiation (TMPPR) for recurrent high-grade gliomas, Alonso La Rosa de los Rios, Alonso Gutierrez, Yazmin Odia, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha
Association of High-Risk Obstructive Sleep Apnea with Endothelial Dysfunction in a Large population-based sample in MiHeart Study, Atulya Khosla, Anshul Saxena, Shozab Ali, Theodore Feldman, Jonathan Fialkow, and Harneet Walia
Dosimetric Comparison of GammaTile® Implants to Stereotactic Radiotherapy for Recurrent Brain Metastasis Resection Cavities., Robert Herrera, Rupesh Kotecha, D Jay Wieczorek, Zachary Fellows, Vibha Chaswal, Vivek Mishra, Michael McDermott, Vitaly Siomin, Minesh Mehta, Alonso Gutierrez, and Ranjini Tolakanahalli
GammaTile® brachytherapy versus stereotactic radiotherapy: A dosimetric comparison for the treatment of recurrent brain metastasis resection cavities, Robert Herrera, Rupesh Kotecha, Tugce Kutuk, D Jay Wieczorek, Zachary Fellows, Vibha Chaswal, Vivek Mishra, Michael McDermott, Minesh Mehta, Alonso Gutierrez, and Ranjini Tolakanahalli
Multi-institutional outcomes of proton beam therapy for hepatocellular carcinoma from the Proton Collaborative Group REG001-09 stud, Michael Chuong and Muni Rubens
The A3i System Significantly Reduces Treatment Times for MRLinac Radiotherapy, Robert Herrera, Michael Chuong, Kathryn Mittauer, James McCulloch, Diane Alvarez, Nema Bassiri-Gharb, Ranjini Tolakanahalli, Adeel Kaiser, Matthew Hall, Rupesh Kotecha, Minesh Mehta, and Alonso Gutierrez
Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant, Guenther Koehne
A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer, Kathryn Mittauer and Michael Chuong
A novel multi-task hybrid deep neural network (DNN) predicts tumor progression during MRgRT, Kathryn Mittauer and Rupesh Kotecha
Dosimetric evaluation of accelerated partial breast irradiation using SAVI & TRIUMPH-T trial regimen, Ranjini Tolakanahalli, Marc Morcos, Tino Romaguera, Alonso Gutierrez, Usha Abraham, Maria-Amelia Rodrigues, and Vibha Chaswal
Dosimetric Evaluation of an MR Linac System compared to Multiple Stereotactic Radiotherapy systems, Ranjini Tolakanahalli, Rupesh Kotecha, D Jay Wieczorek, Kathryn Mittauer, Nema Bassiri-Gharb, Matthew Hall, Michael Chuong, Minesh Mehta, Michael McDermott, and Alonso Gutierrez
Evaluating the Efficacy of Virtual Rounds on Hospitalized Stroke Patients during the COVID-19 Pandemic, Victoria McCue, Michelle Smith, Sonia George, Julia Caballero, Sarah Cano, and Andrea Castillo
Evaluation of an interactive, multi-language, neurocognitive app in CNS radiation oncology, Rupesh Kotecha, Tugce Kutuk, Muni Rubens, Yazmin Odia, Matthew Hall, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, Suyen Ramos, and Miguel Ramirez Menendez
Initial Assessment of Adaptive Pancreas SBRT Treatment Efficiency using ViewRay MRIdian A3i, Kathryn Mittauer, Robert Herrera, James McCulloch, Diane Alvarez, Ranjini Tolakanahalli, Adeel Kaiser, Matthew Hall, Rupesh Kotecha, Minesh Mehta, Michael Chuong, and Nema Bassiri-Gharb
Keep Your Eye on the Bundle: Nurse Leaders' Impact on CAUTI and CLASBI Rates, Christina Rodriguez, Rosalina Butao, Andrea Castillo, and Victoria McCue
Phase II trial of single-fraction SABR on 0.35T MRI-linac for thoracic, abdominal, and pelvic tumors, Michael Chuong, Kathryn Mittauer, Martin Tom, Noah Kalman, James McCulloch, Diane Alvarez, Paul Kaywin, Antonio Ucar, Federico Albrecht, Fernando De Zarraga, Santiago Aparo, Guilherme Rabinowits, Muni Rubens, Alonso Gutierrez, Rupesh Kotecha, and Carolina Rojas
Prognostic value of neutrophil/lymphocyte count in pancreas patients receiving ablative MR-guided RT, Michael Chuong, Robert Herrera, Muni Rubens, Antonio Ucar, Fernando De Zarraga, Santiago Aparo, Sarah Joseph, Matthew Hall, Rupesh Kotecha, Adeel Kaiser, and Gigi Estevez
Prospective Study Phase II Trial of Stereotactic MRI-Guided Adaptive Radiotherapy in 1 Fraction: Unplanned Interim Analysis, Michael Chuong, Kathryn Mittauer, Martin Tom, Noah Kalman, James McCulloch, Diane Alvarez, Paul Kaywin, Antonio Ucar, Federico Albrecht, Fernando De Zarraga, Santiago Aparo, Muni Rubens, Alonso Gutierrez, and Rupesh Kotecha
Quality of life after ablative 5-fraction radiation therapy from the phase II SMART pancreas trial, Michael Chuong and Kathryn Mittauer
Theoretical maximum lateral target thickness for Intensity-modulated vaginal brachytherapy, Marc Morcos